DiaCarta
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3857 Breakwater Ave, Hayward, California...Phone Number
(510) 735-8636Website
www.diacarta.comRevenue
$28.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About DiaCarta
DiaCarta is a leading precision diagnostic company specializing in translational genomics and personalized diagnostics, particularly in cancer gene mutation detection. Their innovative technologies, including XNA and isobDNA, enable sensitive and accurate detection of genetic alterations, positioning them as a leader in the precision diagnostic industry. The company offers a comprehensive suite of diagnostic products and services for oncology and infectious diseases, catering to healthcare providers and patients worldwide. With a commitment to advancing precision medicine, DiaCarta collaborates with pharmaceutical and biopharmaceutical companies, as well as clinicians, to enhance patient care.Explore more
DiaCarta Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DiaCarta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at DiaCarta
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on DiaCarta recently announced quarterly report
Check out if DiaCarta is spiking on competitors!
DiaCarta, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once DiaCarta has new funding data
Click to see if DiaCarta had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when DiaCarta launches new products
Check if DiaCarta has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at DiaCarta
Find more new buyers
Compare Similar Companies to DiaCarta
Compare insights from companies similar to DiaCarta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
DiaCarta is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
DiaCarta is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about DiaCarta.
DiaCarta financials insights
Gather financial insights about DiaCarta, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$8M
2018
Series B
$45M
DiaCarta Tech Stack
A closer look at the technologies used by DiaCarta
See more technologies
Most Recent Scoops
Project
Product Development, Research & Development, Medical Research, Pharmaceuticals, Clinical Operations
Partnership
Partnership, Engineering, Clinical Systems
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Event
will be attending the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo conference as an exhibitor. The event will occur from July 24 to July 28, 2022.
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DiaCarta
Sign Up For FreeTo access detailed company insights
DiaCarta is a leading precision diagnostic company specializing in translational genomics and personalized diagnostics, particularly in cancer gene mutation detection. Their innovative technologies, including XNA and isobDNA, enable sensitive and accurate detection of genetic alterations, positioning them as a leader in the precision diagnostic ind... Read More
